Published in Eur J Immunol on January 17, 2011
Regulatory immune cells in transplantation. Nat Rev Immunol (2012) 1.82
Fates of CD4+ T cells in a tolerant environment depend on timing and place of antigen exposure. Am J Transplant (2011) 1.30
Regulatory T-cell therapy in transplantation: moving to the clinic. Cold Spring Harb Perspect Med (2013) 1.29
Functional regulatory T cells produced by inhibiting cyclic nucleotide phosphodiesterase type 3 prevent allograft rejection. Sci Transl Med (2011) 0.99
TCR cross-reactivity and allorecognition: new insights into the immunogenetics of allorecognition. Immunogenetics (2011) 0.94
Translating tolerogenic therapies to the clinic - where do we stand? Front Immunol (2012) 0.91
Transplantation tolerance and its outcome during infections and inflammation. Immunol Rev (2014) 0.86
Do Natural T Regulatory Cells become Activated to Antigen Specific T Regulatory Cells in Transplantation and in Autoimmunity? Front Immunol (2013) 0.84
Current status of immunomodulatory and cellular therapies in preclinical and clinical islet transplantation. J Transplant (2011) 0.83
T Cells: Soldiers and Spies-The Surveillance and Control of Effector T Cells by Regulatory T Cells. Clin J Am Soc Nephrol (2015) 0.82
Regulatory T cells in transplantation. Transplant Proc (2011) 0.81
The effects of leflunomide on CD4(+)CD25 (+)Foxp3 (+) T regulatory cells in mice receiving allogeneic bone marrow transplantation. Inflamm Res (2011) 0.81
A diametric role for OX40 in the response of effector/memory CD4+ T cells and regulatory T cells to alloantigen. J Immunol (2013) 0.81
Transplantation tolerance. Pediatr Nephrol (2013) 0.78
Anti-CD45RB and donor-specific spleen cells transfusion inhibition allograft skin rejection mediated by memory T cells. Immunol Cell Biol (2016) 0.75
Old game, new players: Linking classical theories to new trends in transplant immunology. World J Transplant (2017) 0.75
Differential sensitivity of regulatory and effector T cells to cell death: a prerequisite for transplant tolerance. Front Immunol (2015) 0.75
Immunological aspects of liver cell transplantation. World J Transplant (2016) 0.75
Quantification of CD4(+) T Cell Alloreactivity and Its Control by Regulatory T Cells Using Time-Lapse Microscopy and Immune Synapse Detection. Am J Transplant (2016) 0.75
mTOR inhibitors effects on regulatory T cells and on dendritic cells. J Transl Med (2016) 0.75
Anti-Interleukin-6 Promotes Allogeneic Bone Marrow Engraftment and Prolonged Graft Survival in an Irradiation-Free Murine Transplant Model. Front Immunol (2017) 0.75
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature (2006) 46.36
Control of regulatory T cell development by the transcription factor Foxp3. Science (2003) 40.32
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol (2003) 38.57
Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity (2005) 23.00
Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol (2006) 14.33
TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature (2008) 14.26
Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet (2001) 14.15
X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet (2001) 10.92
Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol (2006) 9.42
Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol (2009) 8.65
Plasticity of CD4+ T cell lineage differentiation. Immunity (2009) 8.08
Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med (2000) 6.65
Regulatory T cells in transplantation tolerance. Nat Rev Immunol (2003) 6.42
Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation (1973) 6.01
Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med (2007) 5.52
Infection in solid-organ transplant recipients. N Engl J Med (2007) 5.47
In vivo instruction of suppressor commitment in naive T cells. J Exp Med (2004) 5.47
Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol (2004) 5.24
Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol (2003) 5.07
"Infectious" transplantation tolerance. Science (1993) 4.98
Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches. Science (2009) 4.80
Developmental regulation of Foxp3 expression during ontogeny. J Exp Med (2005) 4.32
Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant (2004) 4.04
Nonself-antigens are the cognate specificities of Foxp3+ regulatory T cells. Immunity (2007) 3.98
Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen. J Exp Med (2005) 3.70
Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants. J Immunol (2004) 3.62
CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol (2002) 3.41
CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion. J Immunol (2004) 3.36
Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens. J Exp Med (2006) 3.22
IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol (2001) 3.22
CD3-specific antibodies: a portal to the treatment of autoimmunity. Nat Rev Immunol (2007) 3.06
Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med (1999) 2.74
Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus. J Exp Med (2005) 2.42
TLR engagement prevents transplantation tolerance. Am J Transplant (2006) 2.36
Malignancy after transplantation. Transplantation (2005) 1.92
Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance. J Immunol (2002) 1.85
Allograft rejection mediated by memory T cells is resistant to regulation. Proc Natl Acad Sci U S A (2007) 1.81
Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation (2005) 1.62
Alloantigen-induced CD25+CD4+ regulatory T cells can develop in vivo from CD25-CD4+ precursors in a thymus-independent process. J Immunol (2004) 1.59
CD4+ CD25+ FOXP3+ regulatory T cells increase de novo in kidney transplant patients after immunodepletion with Campath-1H. Am J Transplant (2008) 1.55
The complementary roles of deletion and regulation in transplantation tolerance. Nat Rev Immunol (2003) 1.50
Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients. Am J Transplant (2003) 1.47
Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner. J Immunol (2000) 1.41
Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action. J Exp Med (1990) 1.35
Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 months in renal-transplant recipients. Transplantation (2004) 1.25
Alloreactivity in renal transplant recipients with and without chronic allograft nephropathy. J Am Soc Nephrol (2004) 1.22
Homeostatic proliferation of lymphocytes results in augmented memory-like function and accelerated allograft rejection. J Immunol (2008) 1.17
Location and time-dependent control of rejection by regulatory T cells culminates in a failure to generate memory T cells. J Immunol (2008) 1.09
GITR ligation blocks allograft protection by induced CD25+CD4+ regulatory T cells without enhancing effector T-cell function. Am J Transplant (2007) 1.05
Kinetics of induction of transplantation tolerance with a nondepleting anti-Cd4 monoclonal antibody and donor-specific transfusion before transplantation. A critical period of time is required for development of immunological unresponsiveness. Transplantation (1996) 0.96
Anti-CD4-mediated selection of Treg in vitro - in vitro suppression does not predict in vivo capacity to prevent graft rejection. Eur J Immunol (2008) 0.95
Beyond histology: novel tools to diagnose allograft dysfunction. Clin J Am Soc Nephrol (2006) 0.93
Differential control of allo-antigen-specific regulatory T cells and effector T cells by anti-CD4 and other agents in establishing transplantation tolerance. Int Immunol (2009) 0.89
Why T cells of thymic versus extrathymic origin are functionally different. J Immunol (2008) 0.89
Alemtuzumab (CAMPATH-1H) for the treatment of acute rejection in kidney transplant recipients: long-term follow-up. Transplantation (2009) 0.85
Disease Ontology: a backbone for disease semantic integration. Nucleic Acids Res (2011) 6.03
Annotating the human genome with Disease Ontology. BMC Genomics (2009) 4.71
Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest (2010) 3.41
CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol (2002) 3.41
A simple method to cure established tumors by inflammatory killing of normal cells. Nat Biotechnol (2004) 2.39
From disease ontology to disease-ontology lite: statistical methods to adapt a general-purpose ontology for the test of gene-ontology associations. Bioinformatics (2009) 2.37
Mechanisms of rejection: current perspectives. Transplantation (2012) 2.19
Mesenchymal stromal cells: facilitators of successful transplantation? Cell Stem Cell (2010) 2.10
IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J Exp Med (2005) 2.07
In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells. Nat Med (2010) 2.01
Regulatory immune cells in transplantation. Nat Rev Immunol (2012) 1.82
Allograft rejection mediated by memory T cells is resistant to regulation. Proc Natl Acad Sci U S A (2007) 1.81
Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9. Diabetes (2009) 1.78
IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival. J Immunol (2011) 1.72
Immune phenotype predicts risk for posttransplantation squamous cell carcinoma. J Am Soc Nephrol (2010) 1.72
Alloantigen-induced CD25+CD4+ regulatory T cells can develop in vivo from CD25-CD4+ precursors in a thymus-independent process. J Immunol (2004) 1.59
Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J Immunol (2002) 1.59
Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age. Liver Transpl (2010) 1.59
Production and implantation of renal extracellular matrix scaffolds from porcine kidneys as a platform for renal bioengineering investigations. Ann Surg (2012) 1.45
GATA-2 reinforces megakaryocyte development in the absence of GATA-1. Mol Cell Biol (2009) 1.44
Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. Am J Transplant (2004) 1.40
Exogenous IFN-gamma ex vivo shapes the alloreactive T-cell repertoire by inhibition of Th17 responses and generation of functional Foxp3+ regulatory T cells. Eur J Immunol (2008) 1.36
The impact of memory T cells on rejection and the induction of tolerance. Transplantation (2006) 1.34
Regenerative medicine as applied to solid organ transplantation: current status and future challenges. Transpl Int (2010) 1.33
Impact of hepatic rearterialization on reperfusion injury and outcome after mouse liver transplantation. Transplantation (2003) 1.31
Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation. Transpl Immunol (2006) 1.28
Cutting Edge: Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients. J Immunol (2011) 1.25
Moving to tolerance: clinical application of T regulatory cells. Semin Immunol (2011) 1.25
Interferon-gamma conditioning ex vivo generates CD25+CD62L+Foxp3+ regulatory T cells that prevent allograft rejection: potential avenues for cellular therapy. Transplantation (2008) 1.22
Neuroprotective effect of curcumin on transient focal cerebral ischemia in rats. Brain Res (2008) 1.20
Inflammatory signalling as mediator of epigenetic modulation in tissue-specific chronic inflammation. Int J Biochem Cell Biol (2008) 1.18
Regenerative medicine and organ transplantation: past, present, and future. Transplantation (2011) 1.14
Recipient memory-like lymphocytes remain unresponsive to graft antigens after CAMPATH-1H induction with reduced maintenance immunosuppression. Transplantation (2006) 1.14
Retracted Solvent molecules bridge the mechanical unfolding transition state of a protein. Proc Natl Acad Sci U S A (2008) 1.14
Curcumin improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats. Neurochem Res (2009) 1.14
Mesenchymal stem cell-based treatment for cartilage defects in osteoarthritis. Mol Biol Rep (2011) 1.14
A recurrent neural network with exponential convergence for solving convex quadratic program and related linear piecewise equations. Neural Netw (2004) 1.13
Chemistry on a single protein, vascular cell adhesion molecule-1, during forced unfolding. J Biol Chem (2004) 1.11
Location and time-dependent control of rejection by regulatory T cells culminates in a failure to generate memory T cells. J Immunol (2008) 1.09
Role of T cells in graft rejection and transplantation tolerance. Expert Rev Clin Immunol (2010) 1.08
Biphasic scaffold for annulus fibrosus tissue regeneration. Biomaterials (2007) 1.07
The impact of Th17 cells on transplant rejection and the induction of tolerance. Curr Opin Organ Transplant (2010) 1.07
Effector and memory CD8+ T cells can be generated in response to alloantigen independently of CD4+ T cell help. J Immunol (2006) 1.07
Embryonic stem cells and their differentiated derivatives have a fragile immune privilege but still represent novel targets of immune attack. Stem Cells (2008) 1.07
Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer. J Urol (2008) 1.05
Transplanting stem cells: potential targets for immune attack. Modulating the immune response against embryonic stem cell transplantation. Adv Drug Deliv Rev (2005) 1.03
Interleukin-23 and TH17 cells in transplantation immunity: does 23+17 equal rejection? Transplantation (2007) 1.03
Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation model. Proc Natl Acad Sci U S A (2013) 1.03
Regulatory T cells in transplantation: transferring mouse studies to the clinic. Transplantation (2009) 1.02
Therapeutic effects of adenovirus-mediated growth and differentiation factor-5 in a mice disc degeneration model induced by annulus needle puncture. Spine J (2009) 1.01
Th17: contributors to allograft rejection and a barrier to the induction of transplantation tolerance? Transplantation (2011) 1.00
Embryonic stem cell transplantation: potential applicability in cell replacement therapy and regenerative medicine. Front Biosci (2007) 1.00
In vivo quantification of VCAM-1 expression in renal ischemia reperfusion injury using non-invasive magnetic resonance molecular imaging. PLoS One (2010) 0.99
Functional regulatory T cells produced by inhibiting cyclic nucleotide phosphodiesterase type 3 prevent allograft rejection. Sci Transl Med (2011) 0.99
Stabilization provided by neighboring strands is critical for the mechanical stability of proteins. Biophys J (2008) 0.97
Intravenous immunoglobulins promote skin allograft acceptance by triggering functional activation of CD4+Foxp3+ T cells. Transplantation (2010) 0.96
Mechanical signaling on the single protein level studied using steered molecular dynamics. Cell Biochem Biophys (2009) 0.95
Anti-CD4-mediated selection of Treg in vitro - in vitro suppression does not predict in vivo capacity to prevent graft rejection. Eur J Immunol (2008) 0.95
Chemokine gene expression during allograft rejection: comparison of two quantitative PCR techniques. J Immunol Methods (2005) 0.95
Costimulation blockade: current perspectives and implications for therapy. Transplantation (2013) 0.95
Pretransplant blood transfusion without additional immunotherapy generates CD25+CD4+ regulatory T cells: a potential explanation for the blood-transfusion effect. Transplantation (2003) 0.95
Transplantation tolerance: lessons from experimental rodent models. Transpl Int (2007) 0.94
A comparison of protocols used to generate insulin-producing cell clusters from mouse embryonic stem cells. Stem Cells (2008) 0.94
Immunogenicity of embryonic stem cell-derived progenitors after transplantation. Curr Opin Organ Transplant (2011) 0.94
Dolabranes from the Chinese Mangrove, Ceriops tagal. J Nat Prod (2010) 0.94
Novel biodegradable poly(1,8-octanediol malate) for annulus fibrosus regeneration. Macromol Biosci (2007) 0.94
Regulation of transplant arteriosclerosis by CD25+CD4+ T cells generated to alloantigen in vivo. Transplantation (2007) 0.93
Regulatory T cells as modulators of chronic allograft dysfunction. Curr Opin Immunol (2011) 0.93
Peripheral blood sampling for the detection of allograft rejection: biomarker identification and validation. Transplantation (2011) 0.93
Regenerative medicine as applied to general surgery. Ann Surg (2012) 0.92
Induction of transplantation tolerance-the potential of regulatory T cells. Transpl Immunol (2005) 0.92
Ex vivo expanded human regulatory T cells can prolong survival of a human islet allograft in a humanized mouse model. Transplantation (2013) 0.92
Granatumins A-G, limonoids from the seeds of a Krishna mangrove, Xylocarpus granatum. J Nat Prod (2009) 0.91
Variation in MHC expression between undifferentiated mouse ES cells and ES cell-derived insulin-producing cell clusters. Transplantation (2009) 0.91
Translating tolerogenic therapies to the clinic - where do we stand? Front Immunol (2012) 0.91
Regulatory cells in transplantation. Novartis Found Symp (2003) 0.90
Donor reactive regulatory T cells. Curr Opin Organ Transplant (2009) 0.90
Th17 cells in alemtuzumab-treated patients: the effect of long-term maintenance immunosuppressive therapy. Transplantation (2011) 0.90
Dependency of direct pathway CD4+ T cells on CD40-CD154 costimulation is determined by nature and microenvironment of primary contact with alloantigen. J Immunol (2004) 0.90
T regulatory cells and the control of alloimmunity: from characterisation to clinical application. Curr Opin Immunol (2010) 0.90
Mesenchymal stromal cells in transplantation rejection and tolerance. Cold Spring Harb Perspect Med (2013) 0.90
Robust state estimation for uncertain neural networks with time-varying delay. IEEE Trans Neural Netw (2008) 0.90
Characteristics of the early immune response following transplantation of mouse ES cell derived insulin-producing cell clusters. PLoS One (2010) 0.89
Regulatory T cells in transplantation. Curr Opin Immunol (2002) 0.89
Mesenchymal stem-cell immunosuppressive capabilities: therapeutic implications in islet transplantation. Transplantation (2010) 0.89
Tolerance: one transplant for life. Transplantation (2014) 0.89
Analysis of the peripheral T-cell repertoire in kidney transplant patients. Eur J Immunol (2010) 0.89
Effect and mechanism of ligustrazine on Th1/Th2 cytokines in a rat asthma model. Am J Chin Med (2007) 0.89
CD25+CD4+ regulatory T cells develop in mice not only during spontaneous acceptance of liver allografts but also after acute allograft rejection. Transplantation (2006) 0.89